Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Patients who have been previously surgically diagnosed with endometriosis and have embryos
predicted to be euploid after in vitro fertilization will be divided into 2 groups via
randomization. The test group will receive Elagolix for 60 days prior to starting frozen
embryo transfer preparation. The control group will be given leuprolide acetate every 28 days
x 2 prior to starting the frozen embryo transfer preparation.
Comparative implantation rates between two groups of patients will be evaluated